Skip to main content

Table 2 Relationship between histological entities and MET protein expression and gene copy number in 209 patients with NSCLC

From: Improved diagnostics targeting c-MET in non-small cell lung cancer: expression, amplification and activation?

Histology versus MET expression (formalin)

 

All

MET positive

MET negative

(formalin)

(formalin)

Histology (%)

209 (94.1)

45 (21.5)

164 (78.5)

ADC

110 (48.2)

34 (16.2)

71 (34)

SCC

94 (42.3)

10 (4.8)

77 (36.8)

LCC

9 (4)

1 (0.5)

8 (3.8)

other

9 (4)

0

8 (3.8)

Histology versus MET expression (HOPE)

 

All

MET positive

MET negative

(HOPE)

(HOPE)

Histology (%)

209 (94.1)

77 (36.8)

132 (63.2)

ADC

110 (48.2)

54 (25.8)

51 (24.4)

SCC

94 (42.3)

23 (11)

64 (30.6)

LCC

9 (4)

0 (0)

9 (4.3)

other

9 (4)

0 (0)

8 (3.8)

Histology versus MET phosphorylation at Y1234/1235

 

All

Y1234/1235+

Y1234/1235-

Histology (%)

209 (94.1)

30 (14.4)

179 (85.6)

ADC

110 (48.2)

20 (9.6)

87 (41.6)

SCC

94 (42.3)

9 (4.3)

77 (36.9)

LCC

9 (4)

1 (0.5)

7 (3.3)

other

9 (4)

0

8 (3.8)

Histology versus MET phosphorylation at Y1349

 

All

Y1349+

Y1349-

Histology (%)

209 (94.1)

38 (18.1)

171 (81.8)

ADC

110 (48.2)

17 (8.1)

91 (43.5)

SCC

94 (42.3)

18 (8.6)

67 (32.1)

LCC

9 (4)

3 (1.4)

5 (2.4)

other

9 (4)

0

8 (3.8)

Histology versus MET gene copy number

 

All

FISH positive

FISH positive

(amplification)

(polysomy)

Histology (%)

209 (94.1)

8 (3.8)

5 (2.4)

ADC

110 (48.2)

5 (2.4)

3 (1.4)

SCC

94 (42.3)

3 (1.4)

0 (0)

LCC

9 (4)

0 (0)

2 (1)

other

9 (4)

0 (0)

0 (0)